Cargando…

Novel Tools for Prostate Cancer Prognosis, Diagnosis, and Follow-Up

Prostate-specific antigen (PSA) is the main diagnostic tool when it comes to prostate cancer but it possesses serious limitations. Therefore, there is an urgent need for more sensitive and specific biomarkers for prostate cancer prognosis and patient follow-up. Recent advances led to the discovery o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dimakakos, Andreas, Armakolas, Athanasios, Koutsilieris, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4024423/ https://www.ncbi.nlm.nih.gov/pubmed/24877145 http://dx.doi.org/10.1155/2014/890697

Ejemplares similares

Possible role of the Ec peptide of IGF-1Ec in cartilage repair
por: Armakolas, Nikolaos, et al.
Publicado: (2016)

Evidence for the Possible Biological Significance of the igf-1 Gene Alternative Splicing in Prostate Cancer
por: Philippou, Anastassios, et al.
Publicado: (2013)

IL-6 is associated to IGF-1Ec upregulation and Ec peptide secretion, from prostate tumors
por: Armakolas, A., et al.
Publicado: (2018)

Liquid Biopsies, Novel Approaches and Future Directions
por: Armakolas, Athanasios, et al.
Publicado: (2023)

Unveiling the Immune Microenvironment’s Role in Breast Cancer: A Glimpse into Promising Frontiers
por: Kotsifaki, Amalia, et al.
Publicado: (2023)

Mobile PSA: A Novel Telehealth Tool for Prostate Cancer Follow-Up
por: Bergroth, Robin, et al.
Publicado: (2021)

The role of Ki-67 in the proliferation and prognosis of breast cancer molecular classification subtypes
por: Stathopoulos, George P., et al.
Publicado: (2014)

Exosomes in Prostate Cancer Diagnosis, Prognosis and Therapy
por: Lorenc, Tomasz, et al.
Publicado: (2020)

DKK-1 in prostate cancer diagnosis and follow up
por: D’Amelio, Patrizia, et al.
Publicado: (2014)

Immune System and Hepatocellular Carcinoma (HCC): New Insights into HCC Progression
por: Kotsari, Maria, et al.
Publicado: (2023)

MicroRNAs as clinical tools for diagnosis, prognosis, and therapy in prostate cancer
por: Ghamlouche, Fatima, et al.
Publicado: (2023)

Ariadne’s Thread in the Network of Hepatocellular Carcinoma Immunobiology
por: Koskinas, John, et al.
Publicado: (2021)

MicroRNAs as Biomarkers for Diagnosis, Prognosis and Theranostics in Prostate Cancer
por: Bertoli, Gloria, et al.
Publicado: (2016)

Liquid Biopsy in Diagnosis and Prognosis of Non-Metastatic Prostate Cancer
por: Rzhevskiy, Alexey S., et al.
Publicado: (2022)

Ketamine-induced neurotoxicity in neurodevelopment: A synopsis of main pathways based on recent in vivo experimental findings
por: Kalopita, Konstantina, et al.
Publicado: (2021)

Prostate-specific antigen velocity in diagnosis and prognosis of prostate cancer - a systematic review
por: Javaeed, Arslaan, et al.
Publicado: (2020)

Follow-up and prognosis of HCM
por: Dominguez, Fernando, et al.
Publicado: (2018)

Prostatic mapping in diagnosis and follow-up for prostatic cancer patients treated by CT-RT
por: Azzarello, Guido, et al.
Publicado: (2009)

Prostate Cancer Liquid Biopsy Biomarkers’ Clinical Utility in Diagnosis and Prognosis
por: Matuszczak, Milena, et al.
Publicado: (2021)

The urine foaming test in COVID-19 as a useful tool in diagnosis, prognosis and follow-up: Preliminary results
por: Kurtulmus, Mehmet Serhan, et al.
Publicado: (2020)

Thyroid Papillary Microcarcinoma: Etiology, Clinical Manifestations,Diagnosis, Follow-up, Histopathology and Prognosis
por: Dideban, Shiva, et al.
Publicado: (2016)

Novel biomarkers for the diagnosis and prognosis of colorectal cancer
por: Oh, Hyung-Hoon, et al.
Publicado: (2020)

The Role of PSMA PET/CT in the Primary Diagnosis and Follow-Up of Prostate Cancer—A Practical Clinical Review
por: Lisney, Anna Rebecca, et al.
Publicado: (2022)

Diagnosis and Prognosis of Prostate Cancer from Circulating Matrix Metalloproteinases and Inhibitors
por: El-Chaer, William Khalil, et al.
Publicado: (2018)

Physical Exercise Restrains Cancer Progression through Muscle-Derived Factors
por: Papadopetraki, Argyro, et al.
Publicado: (2022)

Blood-Derived Biomarkers of Diagnosis, Prognosis and Therapy Response in Prostate Cancer Patients
por: Balázs, Katalin, et al.
Publicado: (2021)

Prognosis and Follow-Up of Idiopathic Pulmonary Fibrosis
por: Fernández Fabrellas, Estrella, et al.
Publicado: (2018)

Tumor-derived extracellular vesicles: Potential tool for cancer diagnosis, prognosis, and therapy
por: Saleem, Tayyaba, et al.
Publicado: (2022)

Ion Channels as Potential Tools for the Diagnosis, Prognosis, and Treatment of HPV-Associated Cancers
por: Chiliquinga, Andrea Jazmín, et al.
Publicado: (2023)

Exosomal Components and Modulators in Colorectal Cancer: Novel Diagnosis and Prognosis Biomarkers
por: Chang, Yu-Chan, et al.
Publicado: (2021)

Development and validation of a 25-Gene Panel urine test for prostate cancer diagnosis and potential treatment follow-up
por: Johnson, Heather, et al.
Publicado: (2020)

Nanobodies: a tool to open new horizons in diagnosis and treatment of prostate cancer
por: Hosseindokht, Maryam, et al.
Publicado: (2021)

Thiol Groups as a Biomarker for the Diagnosis and Prognosis of Prostate Cancer
por: Koike, Alexsandro, et al.
Publicado: (2020)

Commercialized Blood-, Urinary- and Tissue-Based Biomarker Tests for Prostate Cancer Diagnosis and Prognosis
por: Visser, Wieke C. H., et al.
Publicado: (2020)

Anxiety and depression after prostate cancer diagnosis and treatment: 5-year follow-up
por: Korfage, I J, et al.
Publicado: (2006)

Epigenetic effects of lung cancer predisposing factors impact on clinical diagnosis and prognosis
por: Piperi, Christina, et al.
Publicado: (2008)

Anxiety and Depression in Patients with Prostate Cancer, at Cancer Diagnosis and after a One-Year Follow-Up
por: Duarte, Vítor, et al.
Publicado: (2022)

On the Road to Accurate Protein Biomarkers in Prostate Cancer Diagnosis and Prognosis: Current Status and Future Advances
por: Yan, Yiwu, et al.
Publicado: (2021)

Diagnosis delay and follow-up strategies in colorectal cancer. Prognosis implications: a study protocol
por: Pita Fernández, Salvador, et al.
Publicado: (2010)

Tinzaparin Safety in Patients With Cancer and Renal Impairment: A Systematic Review
por: Vathiotis, I. A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ehtaipfa9l0bpkd621dil4dvuf